Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 24 | 21 | −3 |
| Shares | 804.0K | 602.5K | −201.5K (−25.1%) |
| Value | $4.28M | $3.30M | −$982.4K (−23.0%) |
New holders (3)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T3 Companies, LLC | 38,000 | $207.8K | 0.27% |
| Nano Cap New Millennium Growth Fund L P | 20,500 | $112.1K | 0.10% |
| Citigroup Inc | 256 | $1.40K | 0.00% |
Sold out (6)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Tang Capital Management LLC | 66,879 | $355.8K |
| Samsara BioCapital, LLC | 48,830 | $259.8K |
| Susquehanna International Group, LLP | 16,642 | $88.5K |
| Squarepoint Ops LLC | 14,836 | $78.9K |
| DRW Securities, LLC | 12,322 | $65.6K |
| Salem Investment Counselors Inc | 2 | $11 |